# US 2013/0157998 A1 · Heterocyclic inhibitors of glutaminase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157998 A1
- Document ID: US20130157998A1
- Status: Published application
- Kind: A1
- Application number: 13/680,582
- Filed: 2012-11-19
- Published: 2013-06-20
- Earliest claimed: 2011-11-21
- Assignees: Calithera Biosciences, Inc.
- Inventors: Jim Li; Lijing Chen; Bindu Goyal; Guy Laidig; Timothy Friend Stanton; Eric Brian Sjogren
- Web page: https://patentgrep.com/patent/US20130157998A1

## CPC

- C07D 417/14: containing three or more hetero rings
- A61B 18/02: by cooling, e.g. cryogenic techniques
- A61K 31/433: Thidiazoles
- A61K 31/501: not condensed and containing further heterocyclic rings
- A61K 31/506: not condensed and containing further heterocyclic rings
- A61K 31/5377: not condensed and containing further heterocyclic rings, e.g. timolol
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61N 5/00: Radiation therapy (ultrasound therapy A61N7/00; devices or apparatus applicable to both therapy and diagnosis A61B6/00)
- A61N 5/10: X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy (A61N5/01 takes precedence)
- A61N 7/00: Ultrasound therapy (lithotripsy A61B17/22, A61B17/225; massage using supersonic vibration A61H23/00 {; using ultrasound for introducing media into the body A61M37/0092})
- C07D 285/125: with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
- C07D 285/135: Nitrogen atoms
- C07D 417/06: linked by a carbon chain containing only aliphatic carbon atoms
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

The invention relates to novel heterocyclic compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel heterocyclic compounds of the invention.

## Claims

### Claim 1

A method of treating cancer or immunological or neurological diseases comprising administering a compound of formula I,
or a pharmaceutically acceptable salt thereof, wherein:
L represents CH2SCH2, CH2CH2, CH2CH2CH2, CH2, CH2S, SCH2, CH2NHCH2, CH═CH, or
wherein any hydrogen atom of a CH or CH2 unit may be replaced by alkyl or alkoxy, any hydrogen of an NH unit may be replaced by alkyl, and any hydrogen atom of a CH2 unit of CH2CH2, CH2CH2CH2 or CH2 may be replaced by hydroxy;
X, independently for each occurrence, represents S, O or CH═CH, wherein any hydrogen atom of a CH unit may be replaced by alkyl;
Y, independently for each occurrence, represents H or CH2O(CO)R7;
R7, independently for each occurrence, represents H or substituted or unsubstituted alkyl, alkoxy, aminoalkyl, alkylaminoalkyl, heterocyclylalkyl, or heterocyclylalkoxy;
Z represents H or R3(CO);
R1 and R2 each independently represent H, alkyl, alkoxy or hydroxy;
R3, independently for each occurrence, represents substituted or unsubstituted alkyl, hydroxyalkyl, aminoalkyl, acylaminoalkyl, alkenyl, alkoxy, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, heteroaryloxyalkyl or C(R8)(R9)(R10), N(R4)(R5) or OR6, wherein any free hydroxyl group may be acylated to form C(O)R7;
R4 and R5 each independently represent H or substituted or unsubstituted alkyl, hydroxyalkyl, acyl, aminoalkyl, acylaminoalkyl, alkenyl, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, or heteroaryloxyalkyl, wherein any free hydroxyl group may be acylated to form C(O)R7;
R6, independently for each occurrence, represents substituted or unsubstituted alkyl, hydroxyalkyl, aminoalkyl, acylaminoalkyl, alkenyl, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, or heteroaryloxyalkyl, wherein any free hydroxyl group may be acylated to form C(O)R7; and
R8, R9 and R10 each independently represent H or substituted or unsubstituted alkyl, hydroxy, hydroxyalkyl, amino, acylamino, aminoalkyl, acylaminoalkyl, alkoxycarbonyl, alkoxycarbonylamino, alkenyl, alkoxy, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, or heteroaryloxyalkyl, or R8 and R9 together with the carbon to which they are attached, form a carbocyclic or heterocyclic ring system, wherein any free hydroxyl group may be acylated to form C(O)R7, and wherein at least two of R8, R9 and R10 are not H.

### Claim 2 (depends on 1)

The method of claim 1, wherein L represents CH2SCH2, CH2CH2, CH2S or SCH2.

### Claim 3 (depends on 1)

The method of claim 1, wherein L represents CH2CH2.

### Claim 4

The method of any preceding claim, wherein Y represents H.

### Claim 5

The method of any preceding claim, wherein X, independently for each occurrence, represents S or CH═CH, wherein any hydrogen atom of a CH unit may be replaced by alkyl.

### Claim 6

The method of any preceding claim, wherein Z represents R3(CO).

### Claim 7 (depends on 6)

The method of claim 6, wherein each occurrence of R3 is not identical.

### Claim 8

The method of any preceding claim, wherein R1 and R2 each represent H.

### Claim 9

The method of any preceding claim, wherein R3, independently for each occurrence, represents substituted or unsubstituted arylalkyl, heteroarylalkyl, cycloalkyl or heterocycloalkyl.

### Claim 10

The method of any preceding claim, wherein R3, independently for each occurrence, represents C(R8)(R9)(R10), wherein R8 represents substituted or unsubstituted aryl, arylalkyl, heteroaryl or heteroaralkyl, R9 represents H, and R10 represents hydroxy, hydroxyalkyl, alkoxy or alkoxyalkyl.

### Claim 11 (depends on 10)

The method of claim 10, wherein R8 represents substituted or unsubstituted aryl, arylalkyl, or heteroaryl.

### Claim 12 (depends on 10, 11)

The method of claim 10 or 11, wherein R10 represents hydroxy, hydroxyalkyl, or alkoxy.

### Claim 13 (depends on 1)

The method of claim 1, wherein L represents CH2SCH2, CH2CH2, CH2S or SCH2, Y represents H, X represents S, Z represents R3(CO), R1 and R2 each represent H, and R3, independently for each occurrence, represents substituted or unsubstituted arylalkyl, heteroarylalkyl, cycloalkyl or heterocycloalkyl.

### Claim 14 (depends on 13)

The method of claim 13, wherein each occurrence of R3 is identical.

### Claim 15 (depends on 1)

The method of claim 1, wherein L represents CH2SCH2, CH2CH2, CH2S or SCH2, Y represents H, X represents S, Z represents R3(CO), R1 and R2 each represent H, and R3, independently for each occurrence, represents C(R8)(R9)(R10), wherein R8 represents substituted or unsubstituted aryl, arylalkyl, heteroaryl or heteroaralkyl, R9 represents H, and R10 represents hydroxy, hydroxyalkyl, alkoxy or alkoxyalkyl.

### Claim 16 (depends on 15)

The method of claim 15, wherein L represents CH2CH2.

### Claim 17 (depends on 15, 16)

The method of claim 15 or 16, wherein R8 represents substituted or unsubstituted aryl, arylalkyl or heteroaryl.

### Claim 18 (depends on 17)

The method of claim 17, wherein R8 represents substituted or unsubstituted aryl.

### Claim 19 (depends on 15, 16, 17, 18)

The method of any of claims 15-18, wherein R10 represents hydroxy, hydroxyalkyl or alkoxy.

### Claim 20 (depends on 19)

The method of claim 19, wherein R10 represents hydroxyalkyl.

### Claim 21 (depends on 15, 16, 17, 18, 19, 20)

The method of any one of claims 15-20, wherein each occurrence of R3 is identical.

### Claim 22 (depends on 1)

The method of claim 1, wherein L represents CH2CH2, Y represents H, X, independently for each occurrence, represents S or CH═CH, Z represents R3(CO), R1 and R2 each represent H, and R3, independently for each occurrence, represents arylalkyl, heteroarylalkyl, cycloalkyl or heterocycloalkyl.

### Claim 23 (depends on 22)

The method of claim 22, wherein each occurrence of R3 is identical.

### Claim 24

A pharmaceutical composition comprising one or more pharmaceutically acceptable excipients and a compound of formula I,
or a pharmaceutically acceptable salt thereof, wherein:
L represents CH2SCH2, CH2CH2, CH2CH2CH2, CH2, CH2S, SCH2, CH2NHCH2, CH═CH, or
wherein any hydrogen atom of a CH or CH2 unit may be replaced by alkyl or alkoxy, any hydrogen of an NH unit may be replaced by alkyl, and any hydrogen atom of a CH2 unit of CH2CH2, CH2CH2CH2 or CH2 may be replaced by hydroxy;
X, independently for each occurrence, represents S, O or CH═CH, wherein any hydrogen atom of a CH unit may be replaced by alkyl;
Y, independently for each occurrence, represents H or CH2O(CO)R7;
R7, independently for each occurrence, represents H or substituted or unsubstituted alkyl, alkoxy, aminoalkyl, alkylaminoalkyl, heterocyclylalkyl, or heterocyclylalkoxy;
Z represents H or R3(CO);
R1 and R2 each independently represent H, alkyl, alkoxy or hydroxy;
R3, independently for each occurrence, represents substituted or unsubstituted alkyl, hydroxyalkyl, aminoalkyl, acylaminoalkyl, alkenyl, alkoxy, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, heteroaryloxyalkyl or C(R8)(R9)(R10), N(R4)(R5) or OR6, wherein any free hydroxyl group may be acylated to form C(O)R7;
R4 and R5 each independently represent H or substituted or unsubstituted alkyl, hydroxyalkyl, acyl, aminoalkyl, acylaminoalkyl, alkenyl, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, or heteroaryloxyalkyl, wherein any free hydroxyl group may be acylated to form C(O)R7;
R6, independently for each occurrence, represents substituted or unsubstituted alkyl, hydroxyalkyl, aminoalkyl, acylaminoalkyl, alkenyl, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, or heteroaryloxyalkyl, wherein any free hydroxyl group may be acylated to form C(O)R7; and
R8, R9 and R10 each independently represent H or substituted or unsubstituted alkyl, hydroxy, hydroxyalkyl, amino, acylamino, aminoalkyl, acylaminoalkyl, alkoxycarbonyl, alkoxycarbonylamino, alkenyl, alkoxy, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, or heteroaryloxyalkyl, or R8 and R9 together with the carbon to which they are attached, form a carbocyclic or heterocyclic ring system, wherein any free hydroxyl group may be acylated to form C(O)R7, and wherein at least two of R8, R9 and R10 are not H;
provided that when L represents CH2SCH2, X represents S, and Z represents R3(CO), both R3 groups are not optionally substituted phenyl, aralkyl, heteroaryl, substituted or unsubstituted alkyl, or alkoxy.

### Claim 25 (depends on 24)

The pharmaceutical composition of claim 24, wherein L represents CH2SCH2, CH2CH2, CH2S or SCH2.

### Claim 26 (depends on 24)

The pharmaceutical composition of claim 24, wherein L represents CH2CH2.

### Claim 27 (depends on 24, 25, 26)

The pharmaceutical composition of any of claims 24-26, wherein Y represents H.

### Claim 28 (depends on 24, 25, 26, 27)

The pharmaceutical composition of any of claims 24-27, wherein X, independently for each occurrence, represents S or CH═CH, wherein any hydrogen atom of a CH unit may be replaced by alkyl.

### Claim 29 (depends on 24, 25, 26, 27, 28)

The pharmaceutical composition of any of claims 24-28, wherein Z represents R3(CO).

### Claim 30 (depends on 29)

The pharmaceutical composition of claim 29, wherein each occurrence of R3 is not identical.

### Claim 31 (depends on 24, 25, 26, 27, 28, 29, 30)

The pharmaceutical composition of any of claims 24-30, wherein R1 and R2 each represent H.

### Claim 32 (depends on 24, 25, 26, 27, 28, 29, 30, 31)

The pharmaceutical composition of any of claims 24-31, wherein R3, independently for each occurrence, represents substituted or unsubstituted arylalkyl, heteroarylalkyl, cycloalkyl or heterocycloalkyl.

### Claim 33 (depends on 24, 25, 26, 27, 28, 29, 30, 31, 32)

The pharmaceutical composition of any of claims 24-32, wherein R3, independently for each occurrence, represents C(R8)(R9)(R10), wherein R8 represents substituted or unsubstituted aryl, arylalkyl, heteroaryl or heteroaralkyl, R9 represents H, and R10 represents hydroxy, hydroxyalkyl, alkoxy or alkoxyalkyl.

### Claim 34 (depends on 33)

The pharmaceutical composition of claim 33, wherein R8 represents substituted or unsubstituted aryl, arylalkyl, or heteroaryl.

### Claim 35 (depends on 33, 34)

The pharmaceutical composition of claim 33 or 34, wherein R10 represents hydroxy, hydroxyalkyl, or alkoxy.

### Claim 36 (depends on 24)

The pharmaceutical composition of claim 24, wherein L represents CH2CH2, CH2S or SCH2, Y represents H, X represents S, Z represents R3(CO), R1 and R2 each represent H, and R3, independently for each occurrence, represents substituted or unsubstituted arylalkyl, heteroarylalkyl, cycloalkyl or heterocycloalkyl.

### Claim 37 (depends on 24)

The pharmaceutical composition of claim 24, wherein L represents CH2SCH2, Y represents H, X represents S, Z represents R3(CO), R1 and R2 each represent H, and R3, independently for each occurrence, represents substituted or unsubstituted heteroarylalkyl, cycloalkyl or heterocycloalkyl.

### Claim 38 (depends on 36, 37)

The pharmaceutical composition of claim 36 or 37, wherein each occurrence of R3 is identical.

### Claim 39 (depends on 24)

The pharmaceutical composition of claim 24, wherein L represents CH2SCH2, CH2CH2, CH2S or SCH2, Y represents H, X represents S, Z represents R3(CO), R1 and R2 each represent H, and R3, independently for each occurrence, represents C(R8)(R9)(R10), wherein R8 represents substituted or unsubstituted aryl, arylalkyl, heteroaryl or heteroaralkyl, R9 represents H, and R10 represents hydroxy, hydroxyalkyl, alkoxy or alkoxyalkyl.

### Claim 40 (depends on 39)

The pharmaceutical composition of claim 39, wherein L represents CH2CH2.

### Claim 41 (depends on 39, 40)

The pharmaceutical composition of claim 39 or 40, wherein R8 represents substituted or unsubstituted aryl, arylalkyl or heteroaryl.

### Claim 42 (depends on 41)

The pharmaceutical composition of claim 41, wherein R8 represents substituted or unsubstituted aryl.

### Claim 43 (depends on 39, 40, 41, 42)

The pharmaceutical composition of any of claims 39-42, wherein R10 represents hydroxy, hydroxyalkyl or alkoxy.

### Claim 44 (depends on 43)

The pharmaceutical composition of claim 43, wherein R10 represents hydroxyalkyl.

### Claim 45 (depends on 39, 40, 41, 42, 43, 44)

The pharmaceutical composition of any one of claims 39-44, wherein each occurrence of R3 is identical.

### Claim 46 (depends on 24)

The pharmaceutical composition of claim 24, wherein L represents CH2CH2, Y represents H, X, independently for each occurrence, represents S or CH═CH, Z represents R3(CO), R1 and R2 each represent H, and R3, independently for each occurrence, represents substituted or unsubstituted arylalkyl, heteroarylalkyl, cycloalkyl or heterocycloalkyl.

### Claim 47 (depends on 46)

The pharmaceutical composition of claim 46, wherein each occurrence of R3 is identical.

### Claim 48

A compound of formula I,
or a pharmaceutically acceptable salt thereof, wherein:
L represents CH2SCH2, CH2CH2, CH2CH2CH2, CH2, CH2S, SCH2, CH2NHCH2, CH═CH, or
wherein any hydrogen atom of a CH or CH2 unit may be replaced by alkyl or alkoxy, any hydrogen of an NH unit may be replaced by alkyl, and any hydrogen atom of a CH2 unit of CH2CH2, CH2CH2CH2 or CH2 may be replaced by hydroxy;
X, independently for each occurrence, represents S, O or CH═CH, wherein any hydrogen atom of a CH unit may be replaced by alkyl;
Y, independently for each occurrence, represents H or CH2O(CO)R7;
R7, independently for each occurrence, represents H or substituted or unsubstituted alkyl, alkoxy, aminoalkyl, alkylaminoalkyl, heterocyclylalkyl, or heterocyclylalkoxy;
Z represents H or R3(CO);
R1 and R2 each independently represent H, alkyl, alkoxy or hydroxy;
R3, independently for each occurrence, represents substituted or unsubstituted alkyl, hydroxyalkyl, aminoalkyl, acylaminoalkyl, alkenyl, alkoxy, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, heteroaryloxyalkyl or C(R8)(R9)(R10), N(R4)(R5) or OR6, wherein any free hydroxyl group may be acylated to form C(O)R7;
R4 and R5 each independently represent H or substituted or unsubstituted alkyl, hydroxyalkyl, acyl, aminoalkyl, acylaminoalkyl, alkenyl, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, or heteroaryloxyalkyl, wherein any free hydroxyl group may be acylated to form C(O)R7;
R6, independently for each occurrence, represents substituted or unsubstituted alkyl, hydroxyalkyl, aminoalkyl, acylaminoalkyl, alkenyl, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, or heteroaryloxyalkyl, wherein any free hydroxyl group may be acylated to form C(O)R7; and
R8, R9 and R10 each independently represent H or substituted or unsubstituted alkyl, hydroxy, hydroxyalkyl, amino, acylamino, aminoalkyl, acylaminoalkyl, alkoxycarbonyl, alkoxycarbonylamino, alkenyl, alkoxy, alkoxyalkyl, aryl, arylalkyl, aryloxy, aryloxyalkyl, cycloalkyl, cycloalkylalkyl, heterocyclyl, heterocyclylalkyl, heteroaryl, heteroarylalkyl, heteroaryloxy, or heteroaryloxyalkyl, or R8 and R9 together with the carbon to which they are attached, form a carbocyclic or heterocyclic ring system, wherein any free hydroxyl group may be acylated to form C(O)R7, and wherein at least two of R8, R9 and R10 are not H;
provided that when L represents CH2SCH2, X represents S, and Z represents R3(CO), both R3 groups are not optionally substituted phenyl, aralkyl, heteroaryl, substituted or unsubstituted alkyl, or alkoxy;
and further provided that the compound is not one of the following:

### Claim 49 (depends on 48)

The compound of claim 48, wherein L represents CH2SCH2, CH2CH2, CH2S or SCH2.

### Claim 50 (depends on 48)

The compound of claim 48, wherein L represents CH2CH2.

### Claim 51 (depends on 48, 49, 50)

The compound of any of claims 48-50, wherein Y represents H.

### Claim 52 (depends on 48, 49, 50, 51)

The compound of any of claims 48-51, wherein X, independently for each occurrence, represents S or CH═CH, wherein any hydrogen atom of a CH unit may be replaced by alkyl.

### Claim 53 (depends on 48, 49, 50, 51, 52)

The compound of any of claims 48-52, wherein Z represents R3(CO).

### Claim 54 (depends on 53)

The compound of claim 53, wherein each occurrence of R3 is not identical.

### Claim 55 (depends on 48, 49, 50, 51, 52, 53, 54)

The compound of any of claims 48-54, wherein R1 and R2 each represent H.

### Claim 56 (depends on 48, 49, 50, 51, 52, 53, 54, 55)

The compound of any of claims 48-55, wherein R3, independently for each occurrence, represents substituted or unsubstituted arylalkyl, heteroarylalkyl, cycloalkyl or heterocycloalkyl.

### Claim 57 (depends on 48, 49, 50, 51, 52, 53, 54, 55, 56)

The compound of any of claims 48-56, wherein R3, independently for each occurrence, represents C(R8)(R9)(R10), wherein R8 represents substituted or unsubstituted aryl, arylalkyl, heteroaryl or heteroaralkyl, R9 represents H, and R10 represents hydroxy, hydroxyalkyl, alkoxy or alkoxyalkyl.

### Claim 58 (depends on 57)

The compound of claim 57, wherein R8 represents substituted or unsubstituted aryl, arylalkyl, or heteroaryl.

### Claim 59 (depends on 57, 58)

The compound of claim 57 or 58, wherein R10 represents hydroxy, hydroxyalkyl, or alkoxy.

### Claim 60 (depends on 48)

The compound of claim 48, wherein L represents CH2CH2, CH2S or SCH2, Y represents H, X represents S, Z represents R3(CO), R1 and R2 each represent H, and R3, independently for each occurrence, represents substituted or unsubstituted arylalkyl, heteroarylalkyl, cycloalkyl or heterocycloalkyl.

### Claim 61 (depends on 48)

The compound of claim 48, wherein L represents CH2SCH2, Y represents H, X represents S, Z represents R3(CO), R1 and R2 each represent H, and R3, independently for each occurrence, represents substituted or unsubstituted heteroarylalkyl, cycloalkyl or heterocycloalkyl.

### Claim 62 (depends on 60, 61)

The compound of claim 60 or 61, wherein each occurrence of R3 is identical.

### Claim 63 (depends on 48)

The compound of claim 48, wherein L represents CH2SCH2, CH2CH2, CH2S or SCH2, Y represents H, X represents S, Z represents R3(CO), R1 and R2 each represent H, and R3, independently for each occurrence, represents C(R8)(R9)(R10), wherein R8 represents substituted or unsubstituted aryl, arylalkyl, heteroaryl or heteroaralkyl, R9 represents H, and R10 represents hydroxy, hydroxyalkyl, alkoxy or alkoxyalkyl.

### Claim 64 (depends on 63)

The compound of claim 63, wherein L represents CH2CH2.

### Claim 65 (depends on 63, 64)

The compound of claim 63 or 64, wherein R8 represents substituted or unsubstituted aryl, arylalkyl or heteroaryl.

### Claim 66 (depends on 65)

The compound of claim 65, wherein R8 represents substituted or unsubstituted aryl.

### Claim 67 (depends on 63, 64, 65, 66)

The compound of any of claims 63-66, wherein R10 represents hydroxy, hydroxyalkyl or alkoxy.

### Claim 68 (depends on 67)

The compound of claim 67, wherein R10 represents hydroxyalkyl.

### Claim 69 (depends on 63, 64, 65, 66, 67, 68)

The compound of any one of claims 63-68, wherein each occurrence of R3 is identical.

### Claim 70 (depends on 48)

The compound of claim 48, wherein L represents CH2CH2, Y represents H, X, independently for each occurrence, represents S or CH═CH, Z represents R3(CO), R1 and R2 each represent H, and R3, independently for each occurrence, represents substituted or unsubstituted arylalkyl, heteroarylalkyl, cycloalkyl or heterocycloalkyl.

### Claim 71 (depends on 70)

The compound of claim 70, wherein each occurrence of R3 is identical.
